跳至主要内容
临床试验/NCT04302714
NCT04302714已完成不适用

Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer: a Multicenter Prospective Randomized Study

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2017年3月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
165
试验地点
2
主要终点
Detection rate

研究概览

简要总结

Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer: a multicenter prospective randomized study

详细描述

Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Signed informed consent from the patient;
  • Histological diagnosis of endometrial cancer (including type I and II EC);
  • Early stage (FIGO stage < 4);
  • Age older than 18 years.

排除标准

  • Preoperative diagnosis of extra-uterine disease;
  • Preoperative suspicious of gross positive nodes;
  • Execution of neoadjuvant chemotherapy;
  • Contraindication to upfront general anesthesia and or mini-invasive surgery;
  • Systemic infections ongoing;
  • Pregnancy ongoing.

结局指标

主要结局

Detection rate

时间窗: 30 month

assessment of Detection rate in the para-aortic area

次要结局

  • Intraoperative complications(30 month)
  • Detection rate(30 month)
  • Operative time(30 month)
  • Postoperative complications(30 month)

研究者

发起方
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验